Opinion: development of new drugs is still a risky business.
HealthCare Institute of New Jersey, USA.
Bob
B
Franks
D003365:Costs and Cost Analysis; D017277:Drug Approval; D004341:Drug Evaluation / Q000191:economics*; D004345:Drug Industry / Q000191:economics*; D006801:Humans; D012109:Research Support as Topic; D014481:United States